Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.

Last reported valuation
$31.7M
Oct 2026
Priced at
—
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026
How much has Sonire Therapeutics raised?
$39.9Macross 1 recorded rounds · Mar 2026 – Mar 2026

Most recently, Sonire Therapeutics raised $13.5M in its Early Stage VC (Mar 2026).

Free account
More of Sonire Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sonire Therapeutics round by round

1 rounds
Mar 2026Early Stage VC$13.5MSEC filing▮
1 investors participated

How much has Sonire Therapeutics raised?

Sonire Therapeutics has raised $39.9 million in total; 1 of its rounds is on record. The largest on record was a $13.5 million early-stage round in Mar 2026.

Sonire Therapeutics has filed 1 Form D with the SEC, most recently in Apr 2026 ($13.5 million sold to 1 investor).

Sonire Therapeutics investors

27 investors are on record for Sonire Therapeutics, including MedTech Innovator, Mitsubishi UFJ Capital, SBI Investment and J-Startup. The early-stage round in Mar 2026 drew 1 investor.

For fundraisers
Raising for a company like Sonire Therapeutics?

27 investors have backed Sonire Therapeutics.

See all 27 investors →

Frequently asked about Sonire Therapeutics

How much has Sonire Therapeutics raised?
Sonire Therapeutics has raised $39.9M in total across 1 recorded funding rounds.
When was Sonire Therapeutics's last funding round?
Sonire Therapeutics's most recent recorded round was Early Stage VC in Mar 2026, raising $13.5M.